广哈通信公告，第三季度营收为1.38亿元，同比增长68.03%；净利润为1100.09万元，同比增长 68.17%。前三季度营收为3.32亿元，同比增长41.90%；净利润为3543.64万元，同比增长69.09%。 ...

广州广哈通信股份有限公司 2025 年第三季度报告 证券代码：300711 证券简称：广哈通信 公告编号：2025-057 广州广哈通信股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个 别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、完 整。 3.第三季度财务会计报告是否经过审计 □是 否 1 广州广哈通信股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 适用 □不适用 单位：元 | 项目 | 本报告期金额 | 年初至报告期期 | 说明 | | --- | --- | --- | --- | | | | 末金额 | | | 非流动性资产处置损益（包括已计提资产减值准备的 | -49,765.95 | -103,316.10 | 主要系不再使 ...

Core Viewpoint - Guangha Communication has received notification from the Shenzhen Stock Exchange regarding the acceptance of its application for a specific object issuance of A-shares, indicating progress in its capital raising efforts [1] Group 1: Company Announcement - The company announced that it has received a notice from the Shenzhen Stock Exchange regarding the acceptance of its application for issuing shares to specific investors [1] - The application documents submitted by the company were found to be complete by the Shenzhen Stock Exchange, leading to the decision to accept the application [1] - The issuance of A-shares is subject to further review and approval by the Shenzhen Stock Exchange and the China Securities Regulatory Commission, indicating that the process is not yet finalized [1]

Group 1: Jinshi Yao - Jinshi Yao expects net profit for the first three quarters of 2025 to be between 86.61 million and 107 million yuan, representing a year-on-year increase of 48.99% to 83.95% [1] - The net profit after deducting non-recurring gains and losses is projected to be between 69.13 million and 89.45 million yuan, with a year-on-year growth of 32.83% to 71.88% [1] - The company specializes in the research, production, and sales of pharmaceuticals and health foods [1] Group 2: High Energy Environment - High Energy Environment, as a member of a consortium, won a bid for a wastewater treatment facility renovation project valued at 53.64 million yuan [1] - The project has a duration of 9 months [1] - The company focuses on solid waste and hazardous waste resource utilization, environmental operation services, and environmental engineering [2] Group 3: Shentong Technology - Shentong Technology reported a net profit of 113 million yuan for the first three quarters of 2025, a year-on-year increase of 584.07% [3] - The company achieved a revenue of 1.302 billion yuan, reflecting a growth of 34.65% [3] - Shentong Technology specializes in the research and manufacturing of automotive power systems and optical components [3] Group 4: Pianzaihuang - Pianzaihuang reported a net profit of 2.129 billion yuan for the first three quarters of 2025, a year-on-year decrease of 20.74% [4] - The company's revenue for the same period was 7.442 billion yuan, down 11.93% year-on-year [4] - Pianzaihuang operates in the pharmaceutical manufacturing and cosmetics industries [4] Group 5: Yingxi Network - Yingxi Network's net profit for the first three quarters of 2025 was 422 million yuan, up 12.68% year-on-year [5] - The company reported a revenue of 4.293 billion yuan, reflecting an 8.33% increase [5] - Yingxi Network focuses on AI interaction and smart living solutions [5] Group 6: Tengjing Technology - Tengjing Technology achieved a net profit of 63.80 million yuan for the first three quarters of 2025, a year-on-year increase of 15% [6] - The company's revenue was 425 million yuan, up 28.11% year-on-year [6] - Tengjing Technology specializes in precision optical components and optical testing instruments [6] Group 7: Huayuan Biological - Huayuan Biological reported a net profit of 234 million yuan for the first three quarters of 2025, a decrease of 3.07% year-on-year [7] - The company's revenue was 936 million yuan, down 0.20% year-on-year [7] - Huayuan Biological operates in the vitamin and pharmaceutical manufacturing sectors [7] Group 8: Yipin Hong - Yipin Hong's subsidiary received a drug registration certificate for Methanesulfonate Injection, indicating it has passed consistency evaluation [8] - The drug is primarily used for counteracting residual muscle relaxation after surgery and treating myasthenia gravis [8] - Yipin Hong focuses on the research, production, and sales of pharmaceuticals [8] Group 9: Xinjiang Jiaojian - Xinjiang Jiaojian won a bid for a highway construction project valued at 556 million yuan [9] - The company specializes in civil engineering and infrastructure construction [9] Group 10: Shenneng Shares - Shenneng Shares reported a 2.6% decrease in electricity generation for the first three quarters of 2025, totaling 43.374 billion kWh [10] - The average on-grid electricity price was 0.497 yuan per kWh [10] - The company focuses on electricity and natural gas development and management [10] Group 11: Xinhua Medical - Xinhua Medical received registration certificates for two new Class II medical devices [11] - The products include a dental implant mobile device and a mobile laser simulation positioning system [11] - Xinhua Medical specializes in the manufacturing and sales of medical devices and pharmaceutical equipment [11] Group 12: Jingneng Power - Jingneng Power reported a 2.91% decrease in on-grid electricity for the first three quarters of 2025, totaling 66.469 billion kWh [12] - The company focuses on electricity and heat production and sales [12] Group 13: Tunnel Shares - Tunnel Shares reported a total bid amount of 69.029 billion yuan for the first three quarters of 2025, a year-on-year increase of 5.06% [13] - The company specializes in urban infrastructure design and construction [13] Group 14: Yongmaotai - Yongmaotai signed a strategic cooperation framework agreement with a leading humanoid robot company [14] - The collaboration will focus on the development of new materials and the establishment of a super supply chain platform [14] - Yongmaotai specializes in the research and production of aluminum alloys and automotive components [14] Group 15: China Nuclear Construction - China Nuclear Construction reported new contracts totaling 1129.62 billion yuan and revenue of 731.80 billion yuan [15] - The company focuses on nuclear power engineering and industrial construction [15] Group 16: Changchun High-tech - Changchun High-tech's subsidiary received FDA acceptance for a clinical trial application for a targeted drug for advanced solid tumors [17] - The drug has also been accepted for clinical trials in China [17] - The company specializes in biopharmaceuticals and traditional Chinese medicine [17] Group 17: Baiyun Mountain - Baiyun Mountain's subsidiary has initiated a Phase III clinical trial for a throat medication [18] - The product is exclusively owned by Wanglaoji [18] - Baiyun Mountain operates in the pharmaceutical and health product sectors [18] Group 18: Jincheng Pharmaceutical - Jincheng Pharmaceutical's subsidiary received approval for a supplemental application for a drug used to treat menopausal symptoms [19] - The approval allows changes in excipients and production processes [19] - Jincheng Pharmaceutical specializes in the research and production of pharmaceuticals [19] Group 19: Zhonghong Medical - Zhonghong Medical's subsidiary obtained registration certificates for two types of disposable nutrition pump tubes [20] - The products are designed for delivering nutritional fluids [20] - Zhonghong Medical focuses on health protection products and medical devices [20] Group 20: Bichuang Technology - Bichuang Technology's vice president resigned for personal reasons [21] - The company specializes in intelligent sensing and precision optical instruments [21] Group 21: Guangha Communication - Guangha Communication's application for a specific stock issuance has been accepted by the Shenzhen Stock Exchange [23] - The company provides communication network solutions for various industries [23] Group 22: Buchang Pharmaceutical - Buchang Pharmaceutical's subsidiary signed a contract for pharmacokinetics and toxicology testing worth 10.8 million yuan [24] - The company specializes in traditional Chinese medicine [24] Group 23: Jinchuan Group - Jinchuan Group's shareholder plans to reduce their stake by up to 3% [26] - The company specializes in rail transit vehicle components [26] Group 24: Shandong Road and Bridge - Shandong Road and Bridge's subsidiary plans to acquire a limited partnership interest for 140 million yuan [27] - The company specializes in road and bridge engineering [27] Group 25: TBEA - TBEA's subsidiary plans to acquire a 74.19% stake in Shuguang Cable for 946 million yuan [29] - The company specializes in power transmission and new energy [29] Group 26: Junshi Biological - Junshi Biological's clinical trial for a lung cancer treatment has been approved by the FDA [30] - The company specializes in innovative drug development [30] Group 27: YTO Express - YTO Express's shareholder plans to transfer up to 2% of the company's shares [31] - The company specializes in logistics and express delivery services [31] Group 28: Satellite Chemical - Satellite Chemical's subsidiary has completed maintenance and resumed normal production [32] - The company specializes in chemical production [32] Group 29: Longbai Group - Longbai Group's subsidiary plans to acquire titanium dioxide business assets for 69.9 million USD [33] - The company specializes in titanium dioxide and related products [33] Group 30: Jingda Shares - Jingda Shares' actual controller plans to reduce their stake by up to 3% [34] - The company specializes in special electromagnetic wires and precision molds [34] Group 31: Jinghe Integration - Jinghe Integration's subsidiary plans to implement a capital increase [35] - The company specializes in semiconductor manufacturing [35] Group 32: Zhaofeng Shares - Zhaofeng Shares signed a strategic cooperation agreement with a robotics company [36] - The company specializes in automotive components [36] Group 33: Jiulian Technology - Jiulian Technology announced a three-month delay in disclosing a major asset restructuring plan [37] - The company specializes in smart terminal and communication solutions [37] Group 34: Guosheng Technology - Guosheng Technology's investment target has not yet commenced actual operations [38] - The company specializes in photovoltaic battery production [38] Group 35: Kailong High-tech - Kailong High-tech plans to establish a joint venture with related parties [40] - The company specializes in air pollution control equipment [40] Group 36: Shijia Photon - Shijia Photon reported a net profit of 300 million yuan for the first three quarters of 2025, a year-on-year increase of 727.74% [42] - The company achieved a revenue of 1.56 billion yuan, reflecting a growth of 113.96% [42] - Shijia Photon specializes in optical integrated chips and related technology [42] Group 37: Furan Energy - Furan Energy reported a net profit of 490 million yuan for the first three quarters of 2025, a year-on-year increase of 6.07% [43] - The company achieved a revenue of 23.501 billion yuan, reflecting a growth of 5.38% [43] - Furan Energy specializes in urban gas and renewable energy [43] Group 38: Kanghua Biological - Kanghua Biological reported a net profit of 189 million yuan for the first three quarters of 2025, a year-on-year decrease of 53.41% [44] - The company achieved a revenue of 840 million yuan, down 20.78% year-on-year [44] - Kanghua Biological specializes in vaccine production and sales [44] Group 39: Cangge Mining - Cangge Mining reported a net profit of 2.751 billion yuan for the first three quarters of 2025, a year-on-year increase of 47.26% [45] - The company achieved a revenue of 2.401 billion yuan, reflecting a growth of 3.35% [45] - Cangge Mining specializes in the production and sales of potassium chloride and lithium carbonate [45] Group 40: Huadong CNC - Huadong CNC reported a net profit of 23.12 million yuan for the first three quarters of 2025, a year-on-year increase of 151.78% [47] - The company achieved a revenue of 249 million yuan, down 3.21% year-on-year [47] - Huadong CNC specializes in CNC machine tools and related components [47] Group 41: Yunnan Energy Investment - Yunnan Energy Investment plans to invest 1.872 billion yuan in a compressed air energy storage project [48] - The project will have a capacity of 350MW/1750MWh and is expected to take 18 months to complete [48] - Yunnan Energy Investment specializes in renewable energy and salt production [48] Group 42: Oriental Cable - Oriental Cable announced recent project wins totaling approximately 2.374 billion yuan [49] - The projects include various cable supply and installation works [49] - Oriental Cable specializes in power engineering and cable manufacturing [49]

Group 1 - Zhongchen Co., Ltd. has its last conversion day for "Zhongchen Convertible Bonds" on October 17, after which unconverted bonds will be forcibly redeemed at a price of 100.58 yuan per bond, potentially leading to investment losses for investors [1] - Investors have until the market closes on October 17 to convert their bonds, with only half a trading day remaining before the conversion stops on October 20 [1] Group 2 - Guangha Communication has submitted an application for a specific issuance of A-share stocks, which has been accepted by the Shenzhen Stock Exchange [1]

Core Viewpoint - Guangha Communication (300711.SZ) has received a notification from the Shenzhen Stock Exchange regarding the acceptance of its application for a specific stock issuance [1] Group 1 - The Shenzhen Stock Exchange has verified the application documents submitted by the company for the issuance of stocks to specific investors and found them complete [1] - The exchange has decided to accept the application for the issuance of stocks [1]

Core Viewpoint - Guangha Communication has received notification from the Shenzhen Stock Exchange regarding the acceptance of its application for a specific stock issuance [1] Group 1 - The company has submitted an application for a specific stock issuance to the Shenzhen Stock Exchange [1] - The Shenzhen Stock Exchange has reviewed the application documents and found them complete [1] - The exchange has decided to accept the application for further processing [1]

Core Viewpoint - Guangha Communication has received notification from the Shenzhen Stock Exchange regarding the acceptance of its application for a specific stock issuance to designated objects [1] Group 1 - The company has submitted an application for a specific stock issuance, which has been verified as complete by the Shenzhen Stock Exchange [1] - The Shenzhen Stock Exchange has decided to accept the application for the issuance of stocks [1]

证券代码：300711 证券简称：广哈通信 公告编号：2025-055 广州广哈通信股份有限公司董事会 2025 年 10 月 17 日 获得深圳证券交易所受理的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 广州广哈通信股份有限公司（以下简称"公司"）于日前收到深圳证券交易 所出具的《关于受理广州广哈通信股份有限公司向特定对象发行股票申请文件的 通知》（深证上审〔2025〕185 号）。深圳证券交易所对公司报送的向特定对象发 行股票的申请文件进行了核对，认为申请文件齐备，决定予以受理。 公司本次向特定对象发行 A 股股票事项尚需深圳证券交易所审核通过，并获 得中国证券监督管理委员会同意注册后方可实施。最终能否通过深圳证券交易所 审核并获得中国证券监督管理委员会同意注册的决定及所需时间仍存在不确定 性。公司将根据进展情况及时履行信息披露义务，敬请广大投资者谨慎决策，注 意投资风险。 特此公告。 广州广哈通信股份有限公司 关于 2025 年度向特定对象发行 A 股股票申请 ...

股票简称：广哈通信 股票代码：300711 广州广哈通信股份有限公司 2025年度向特定对象发行A股股票 募集说明书 （申报稿） 保荐人（主承销商） 广东省深圳市福田区中心三路 8 号卓越时代广场（二期）北座 二〇二五年 月 广州广哈通信股份有限公司 2025 年度向特定对象发行 A 股股票募集说明书 声 明 本公司全体董事、审计委员会委员、高级管理人员承诺本募集说明书不存在 任何虚假记载、误导性陈述或重大遗漏，并保证所披露信息的真实、准确、完整。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证 本募集说明书中财务会计报告真实、完整。 证券监督管理机构及其他政府部门对本次发行所作的任何决定，均不表明其 对发行人所发行证券的价值或投资者的收益作出实质性判断或者保证。任何与之 相反的声明均属虚假不实陈述。 根据《证券法》的规定，证券依法发行后，发行人经营与收益的变化，由发 行人自行负责，由此变化引致的投资风险，由投资者自行负责。 1-1-1 广州广哈通信股份有限公司 2025 年度向特定对象发行 A 股股票募集说明书 重大事项提示 本公司特别提醒投资者注意下列重大事项或风险因素，并认真阅读本募 ...